These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1451372)

  • 1. Estrogen replacement and heart disease.
    Walsh BW
    Clin Obstet Gynecol; 1992 Dec; 35(4):894-900. PubMed ID: 1451372
    [No Abstract]   [Full Text] [Related]  

  • 2. [Estrogens in menopause--therapy and prevention. III. Estrogen replacement in menopause: uses and risks in prevention and therapy of cardiovascular diseases].
    Reincke M; Allolio B
    Internist (Berl); 1996 Apr; 37(4):410-5; discussion 415. PubMed ID: 8655282
    [No Abstract]   [Full Text] [Related]  

  • 3. [The story of the reversal of opinion about hormone replacement therapy and cardiovascular disease].
    Løkkegaard EC
    Ugeskr Laeger; 2005 Mar; 167(10):1166-70. PubMed ID: 15810574
    [No Abstract]   [Full Text] [Related]  

  • 4. Risks and benefits of replacement estrogen.
    Barrett-Connor E
    Annu Rev Med; 1992; 43():239-51. PubMed ID: 1580588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current trends in hormone therapy during menopause and postmenopause].
    Suhonen S
    Duodecim; 1994; 110(10):1011-8. PubMed ID: 7588094
    [No Abstract]   [Full Text] [Related]  

  • 6. [Various practical schemes of substitution hormone therapy].
    Gaspard U
    Rev Med Liege; 1994 Apr; 49(4):182-9. PubMed ID: 8209120
    [No Abstract]   [Full Text] [Related]  

  • 7. [Estrogen therapy in climacteric. Current views in an evidence-based perspective].
    Nilsson K
    Lakartidningen; 2001 Jul; 98(28-29):3225-8. PubMed ID: 11496812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormonal treatment for the climacteric: alleviation of symptoms and prevention of postmenopausal disease.
    te Velde ER; van Leusden HA
    Lancet; 1994 Mar; 343(8898):654-8. PubMed ID: 7906817
    [No Abstract]   [Full Text] [Related]  

  • 9. [Benefits and risks of postmenopausal hormone replacement therapy. Symptoms improved but not a better outcome?].
    MMW Fortschr Med; 2010 Jun; 152(24):18. PubMed ID: 20672580
    [No Abstract]   [Full Text] [Related]  

  • 10. [Inconveniences and risks of untreated menopause. Benefits brought by the replacement hormonal treatment].
    Drapier-Faure E
    Rev Fr Gynecol Obstet; 1992; 87(7-9):393-6. PubMed ID: 1332177
    [No Abstract]   [Full Text] [Related]  

  • 11. [Postmenopausal hormone therapy after WHI and HERS].
    Birkhäuser M; de Geyter C; Keller PJ; Luzuy F
    Gynakol Geburtshilfliche Rundsch; 2004 Oct; 44(4):244-8. PubMed ID: 15459524
    [No Abstract]   [Full Text] [Related]  

  • 12. Climacteric symptoms and hormonal replacement therapy: a risk or an opportunity?
    Lindgren R
    Arch Gynecol Obstet; 1993; 253 Suppl():S45-9. PubMed ID: 8117160
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hormone therapy in climacteric. Different effects of estrogen and gestagen on the risk of breast and endometrial cancer].
    Magnusson C; Weiderpass E
    Lakartidningen; 2001 Jan; 98(5):418-21. PubMed ID: 11229082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Principles of replacement hormone therapy in climacteric disorders].
    Smetnik VP
    Akush Ginekol (Mosk); 1995; (3):15-7. PubMed ID: 7653720
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of estrogen replacement therapy on cardiovascular disease: literature review.
    Lehman KD; Calkins JW
    Kans Med; 1988 Nov; 89(11):308-13. PubMed ID: 3060652
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cardiovascular risks under hormone replacement therapy].
    Windler E
    Internist (Berl); 2004 Jul; 45(7):826-34. PubMed ID: 15205743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Estrogen during and after climacteric--problems and possibilities for primary health care].
    Blivik J
    Lakartidningen; 2001 Mar; 98(10):1145-6. PubMed ID: 11301984
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hormone therapy in climacteric. Varying research results on risks and benefits].
    Magnusson C; Persson I
    Lakartidningen; 1997 Mar; 94(13):1176-9. PubMed ID: 9148053
    [No Abstract]   [Full Text] [Related]  

  • 19. [The SBU revises its view on estrogen replacement therapy in climacteric. Evidently increased risk of thrombosis and breast cancer].
    Hovelius B
    Lakartidningen; 2002 Jul; 99(28-29):3014-5. PubMed ID: 12170508
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hepatic changes in different hormone replacement therapies in climacteric].
    Foth D; Römer T; Panzig E
    Zentralbl Gynakol; 1995; 117(7):349-52. PubMed ID: 7668064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.